Taken together, these findings indicate that ITGB3-KD exerts radiosensitizing effects on osteosarcoma cells by promoting osteogenic differentiation and apoptosis through activation of the JNK/c-JUN/RUNX2 pathway (Fig. 9). Here, RUNX2 is linked to osteosarcoma.